Paasa Logo
TScan Therapeutics, Inc. logo
TCRXNASDAQMarket closedOpens 9:30am ET

TScan Therapeutics, Inc.

$0.34Last updated
-$0.01 (2.58%)Past day
Timezone

TScan Therapeutics, Inc. (NASDAQ: TCRX) is trading at $0.34, about ₹33 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 2.58% today. Indian residents can buy TScan Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$0.35
Previous close:$0.35
Volume:381.05K

Today's low

$0.33

Today's high

$0.37

52 week low

$0.29

52 week high

$2.57

TCRX opened at $0.35, closed previously at $0.35, and has traded between $0.29 and $2.57 over the past 52 weeks.

About

TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company’s lead product is TSC-101, for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT), which is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also develops TSC-102-A01 and TSC-102-A03, which are allogeneic and donor-derived TCR-T therapy candidates targeting epitopes. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204 for the treatment of solid tumors. It has a research collaboration and license agreement with Amgen Inc. to identify antigens recognized by T cells in patients with Crohn’s disease. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Country
US
CEO
Gavin MacBeath
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
138
Sector
Healthcare
IPO date
16/07/2021

Key statistics

Avg. volume

754.37K

Market cap

$20.77M

P/E Ratio

-0.37

Price-to-sales ratio

2.92

Enterprise value

$11.50M

Free cash flow yield

-570.37%

Debt-to-equity ratio

1.32

Return on equity

-108.72%

ROIC

-75.38%

Beta

1.07

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$10.32M

Earnings per share

-$1.00

Free cash flow

-$139.73M

Net profit margin

-1655.35%

Gross margin

90.25%

EBITDA

-$124.13M

Revenue growth

266.65%

Similar securities

This is not an investment recommendation

How to buy TScan Therapeutics from India

Indian residents can buy TScan Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for TScan Therapeutics and place an order

    Find TScan Therapeutics by name or by its ticker, TCRX, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. TScan Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your TScan Therapeutics position in USD and INR. TScan Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in TScan Therapeutics from India

Trading and taxes when buying TScan Therapeutics from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneTScan Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy TScan Therapeutics stock?

Yes. TScan Therapeutics (TCRX) has been listed on NASDAQ since 2021, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one TScan Therapeutics share cost in rupees?

One TScan Therapeutics share is $0.34 — about ₹33 at a USD/INR rate of 95.88 on 26 Sep 2026. Both the TScan Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying TScan Therapeutics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of TScan Therapeutics?

Yes. One TScan Therapeutics share is $0.34, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in TScan Therapeutics.

How are gains on TScan Therapeutics shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the TScan Therapeutics price. Paasa issues a capital-gains statement for your return.

Does TScan Therapeutics pay a dividend?

No. TScan Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade TScan Therapeutics from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on TScan Therapeutics shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare TScan Therapeutics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your TScan Therapeutics holding, its cost and its closing value.

How do I sell TScan Therapeutics and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.